Company Update MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Press Release / Media Release BSE India Marksans Pharma Limited announces US FDA approval for Famotidine Tablets USP, 10 mg and 20 mg.